ANLN and cancer: As summarized in Figure 3, AIM1L serves as an independent prognosis predictor for OS in HCC patients after adjusting TTK, ANLN and person neoplasm cancer status (HR = 1.5, 95%CI = 1.02–2.1, P = 0.037, Figure 3).